logo

Pds Biotechnology Corp (PDSB)



Trade PDSB now with
  Date
  Headline
10/4/2021 8:39:50 AM PDS Biotech Enrolls First Stage Of Patient Of Phase 2 Clinical Trial In Advanced HPV-16 Positive Head And Neck Cancer
9/9/2021 8:44:03 AM PDS Biotech Completes Enrollment Of Lead-In Safety Cohort In VERSATILE-002 Phase 2 Combination Trial Of PDS0101-KEYTRUDA
9/9/2021 8:37:48 AM PDS Biotech Completes Enrollment Of VERSATILE-002 Phase 2 Combination Trial Of PDS0101-KEYTRUDA
6/8/2021 6:07:06 AM PDS Biotechnology Announces Presentation Of Interim Data From Phase 2 Trial At ASCO
6/3/2021 8:59:19 AM PDS Biotechnology Announces Protocol Amendment To Expand Its Phase 2 VERSATILE-002 Study
12/9/2020 8:38:54 AM PDS Biotechnology Appoints Seth Van Voorhees As CFO
9/28/2020 8:43:18 AM PDS Biotechnology To Present Results From Its Phase 1 Trial Of PDS0101
6/22/2020 8:40:18 AM PDS Biotech Reports Publication Of Preclinical Results Of PDS0101
6/15/2020 8:48:06 AM PDS Biotechnology Begins Phase 2 Trial Of PDS0101 Led By The National Cancer Institute
5/13/2020 6:07:23 AM PDS Biotechnology Q1 Net Loss $4.0 Mln Or $0.39/shr Vs Income $6.8 Mln Or $1.47/Shr Last Year
3/5/2020 8:43:33 AM PDS Biotechnology Says Granted U.S. Patent No. 15/702,063
2/24/2020 8:45:20 AM PDS Biotechnology Appoints Kamil Ali-Jackson To Board